Drug trial aims to speed healing for critical transplant patients
NCT ID NCT05466201
Summary
This study tested if a drug called Eltrombopag could help patients recover their blood platelet counts more quickly after a stem cell transplant for bone marrow failure diseases. Faster recovery could reduce the need for transfusions, lower infection risk, and shorten hospital stays. The trial involved 118 patients who had received a transplant and aimed to see if the drug safely improved their engraftment process.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
Conditions
Explore the condition pages connected to this study.